SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (1776)2/12/2008 12:04:54 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
OSIP seems to hav found support above the $35 level.<g>

The stock is up 5.49 % with volume of 565,733 about half its ADV

bigcharts.marketwatch.com

OSIP also presented at the MER's conference last week & in Jan it placed $135M of convertible notes with 3% interest & approximate conversion price of $73.82 due in 2038

It has 3Qs of double digit improvements on revenues & the bottom line has improved by triple digits for 4 consecutive Qs.

The EE for 2007 are around $1.66 vs. $0.01 in 2006 & all the previous losses im prior Yrs. since 2000 For 2008 a further improvement to $2/shr is expected.

OSIP has + CF around $0.65 the short ratio came down 5% but is still about 6x its ADV

The "analysts" have a target around $55.13 but it seems that with some good news & a better market environment OSIP could get back above the $65 level.<g>

bigcharts.marketwatch.com

Bernard